Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Ageing - Pipeline Review, H2 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 50 | Code: MRS - 18528


Global Markets Directs, Ageing Pipeline Review, H2 2014, provides an overview of the Ageings therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ageing, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ageing and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides a snapshot of the global therapeutic landscape of Ageing
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Ageing and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Ageing products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Ageing pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Ageing
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Ageing pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Content 

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Global Markets Direct Report Coverage 6
Ageing Overview 7
Therapeutics Development 8
Pipeline Products for Ageing - Overview 8
Pipeline Products for Ageing - Comparative Analysis 9
Ageing - Therapeutics under Development by Companies 10
Ageing - Therapeutics under Investigation by Universities/Institutes 11
Ageing - Pipeline Products Glance 12
Early Stage Products 12
Ageing - Products under Development by Companies 13
Ageing - Products under Investigation by Universities/Institutes 14
Ageing - Companies Involved in Therapeutics Development 15
Bioo Therapeutics 15
Neuralstem, Inc. 16
RepliCel Life Sciences, Inc. 17
RXi Pharmaceuticals Corporation 18
vida therapeutics inc. 19
Ageing - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21
Assessment by Target 22
Assessment by Mechanism of Action 24
Assessment by Route of Administration 26
Assessment by Molecule Type 28
Drug Profiles 30
BIOO-4 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
BIOO-7 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Drugs for Ageing - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
metformin + sirolimus - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
MG-29 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
MMP-26051 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
MMP-26052 - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
NSI-189 - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
RCS-01 - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
sirolimus - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Small Molecule for Alzheimer's Disease and Ageing - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
TM-5441 - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
V-2248 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Ageing - Recent Pipeline Updates 44
Ageing - Dormant Projects 47
Ageing - Product Development Milestones 48
Featured News & Press Releases 48
Oct 09, 2014: RepliCel to Present Commercial and Clinical Update on RCS-01 at BioJapan 2014 World Business Forum 48

Appendix 49
Methodology 49
Coverage 49
Secondary Research 49
Primary Research 49
Expert Panel Validation 49
Contact Us 50
Disclaimer 50

List of Tables

Number of Products under Development for Ageing, H2 2014 8
Number of Products under Development for Ageing - Comparative Analysis, H2 2014 9
Number of Products under Development by Companies, H2 2014 10
Number of Products under Investigation by Universities/Institutes, H2 2014 11
Comparative Analysis by Early Stage Development, H2 2014 12
Products under Development by Companies, H2 2014 13
Products under Investigation by Universities/Institutes, H2 2014 14
Ageing - Pipeline by Bioo Therapeutics, H2 2014 15
Ageing - Pipeline by Neuralstem, Inc., H2 2014 16
Ageing - Pipeline by RepliCel Life Sciences, Inc., H2 2014 17
Ageing - Pipeline by RXi Pharmaceuticals Corporation, H2 2014 18
Ageing - Pipeline by vida therapeutics inc., H2 2014 19
Assessment by Monotherapy Products, H2 2014 20
Assessment by Combination Products, H2 2014 21
Number of Products by Stage and Target, H2 2014 23
Number of Products by Stage and Mechanism of Action, H2 2014 25
Number of Products by Stage and Route of Administration, H2 2014 27
Number of Products by Stage and Molecule Type, H2 2014 29
Ageing Therapeutics - Recent Pipeline Updates, H2 2014 44
Ageing - Dormant Projects, H2 2014 47

List of Figures

Number of Products under Development for Ageing, H2 2014 8
Number of Products under Development for Ageing - Comparative Analysis, H2 2014 9
Number of Products under Development by Companies, H2 2014 10
Number of Products under Investigation by Universities/Institutes, H2 2014 11
Comparative Analysis by Early Stage Products, H2 2014 12
Assessment by Monotherapy Products, H2 2014 20
Number of Products by Top 10 Targets, H2 2014 22
Number of Products by Stage and Top 10 Targets, H2 2014 22
Number of Products by Top 10 Mechanism of Actions, H2 2014 24
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 24
Number of Products by Top 10 Routes of Administration, H2 2014 26
Number of Products by Stage and Top 10 Routes of Administration, H2 2014 26
Number of Products by Top 10 Molecule Types, H2 2014 28
Number of Products by Stage and Top 10 Molecule Types, H2 2014 28

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2000 View Pricing